Concepedia

R.K. Hjortkjaer

RH

Statistics

Publications

5

Citations

125

H-Index

5

Active since

1979

Affiliations

Novo Holdings (Denmark)(Current)

R.K. Hjortkjaer is an author at Novo Holdings (Denmark) specializing in biotechnology, medicine, and microbiology.

Top concepts

Publications per year

1979–2010

5

Publications

5

Colic in the horse. A clinical and clinical chemical study of 42 cases.

Camilla Svendsen, R.K. Hjortkjaer, M. Hesselholt · PubMed · 1979 · 41 citations

, , +19

Degarelix, a novel GnRH antagonist, causes minimal histamine release compared with cetrorelix, abarelix and ganirelix in an <i>ex vivo</i> model of human skin samples

Wolfgang Koechling, R.K. Hjortkjaer, László B. Tankó · British Journal of Clinical Pharmacology · 2010 · 32 citations · Full text

Pharmacokinetics of the neuroprotective glutamate antagonist NBQX (6-nitro-7-sulfamoyl-benzo(f)quinoxaline-2,3-dione) in mice, rats, and dogs. Interactions with probenecid.

Lars Dalgaard, R.K. Hjortkjaer, B. Régnier et al. · Drug Metabolism and Disposition · 1994 · 21 citations

Safety evaluation of celluclast®, an acid cellulase derived from Trichoderma reesei

R.K. Hjortkjaer, Vivi Bille‐Hansen, Keith P. Hazelden et al. · Food and Chemical Toxicology · 1986 · 20 citations

, , +9

Safety evaluation of Streptomyces murinus glucose isomerase

Richard D. Ashby, R.K. Hjortkjaer, M. Stavnsbjerg et al. · Toxicology Letters · 1987 · 11 citations

, , +4

1–5 of 5